Tirzepatide Injectable
Dual GIP/GLP-1 agonist — next-generation weight loss
Select an option
Includes provider review, medication, and shipping.
What Tirzepatide Injectable does for you
Tirzepatide is a dual GIP and GLP-1 receptor agonist, making it one of the most effective weight loss medications available. Clinical trials showed an average weight reduction of up to 22.5%.
Up to 22.5% body weight reduction in trials
Dual-action: targets both GIP and GLP-1 receptors
Reduces visceral fat more effectively than GLP-1 alone
Once-weekly injection
Improved cardiovascular markers
From consultation to your doorstep
Online intake
Complete a brief online health assessment
Provider review
Provider review within 24 hours
Shipped fast
Compounded medication shipped to your door
Ongoing care
Ongoing dose titration and monthly check-ins
Real patients, real results
"Switched from semaglutide and the difference was immediate. Down 35 lbs in 5 months."
— Jennifer L.
"Onboarding was simple, the clinician was thoughtful, and my order arrived faster than I expected."
— Alex P.
"Nuvara is the first telehealth service that actually felt like real medicine."
— Megan L.
"Pricing was transparent up front and the monthly check-ins genuinely help me stay on track."
— Devon R.
"Discreet packaging, fast shipping, and the provider answered every question I had within hours."
— Sophie N.
"Took me about a week to feel the full effect, but the results since then have been consistent."
— Marcus W.
Frequently asked questions
Ready to start with Tirzepatide Injectable?
Complete your intake in under 5 minutes. A licensed clinician will review it within 24 hours.